Evidence map›Paper›PMID 32424733›Full record

ArticleMedical oncology (Northwood, London, England)2020

The texture analysis as a predictive method in the assessment of the cytological specimen of CT-guided FNAC of the lung cancer.

Alfonso Reginelli, Maria Paola Belfiore, Riccardo Monti, Immacolata Cozzolino, Matilde Costa, Giovanni Vicidomini, Roberta Grassi, Floriana Morgillo, Fabrizio Urraro, Valerio Nardone and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Alfonso ReginelliDepartment of Precision Medicine, University of Campania "L. Vanvitelli", 80138, Naples, Italy. alfonso.reginelli@hotmail.com.
Maria Paola BelfioreDepartment of Precision Medicine, University of Campania "L. Vanvitelli", 80138, Naples, Italy.
Riccardo MontiDepartment of Precision Medicine, University of Campania "L. Vanvitelli", 80138, Naples, Italy.
Immacolata CozzolinoDepartment of Mental and Phisic Health and University of Campania, Naples, Italy.
Matilde CostaTecnologie Avanzate TA Srl, Torino, Italy.
Giovanni VicidominiDepartment of Surgery and Medical Science, University of Campania "L. Vanvitelli", Naples, Italy.
Roberta GrassiDepartment of Precision Medicine, University of Campania "L. Vanvitelli", 80138, Naples, Italy.
Floriana MorgilloDepartment of Precision Medicine, University of Campania "L. Vanvitelli", 80138, Naples, Italy.
Fabrizio UrraroDepartment of Precision Medicine, University of Campania "L. Vanvitelli", 80138, Naples, Italy.
Valerio NardoneUnit of Radiation Oncology, Ospedale del Mare, Naples, Italy.
Salvatore CappabiancaDepartment of Precision Medicine, University of Campania "L. Vanvitelli", 80138, Naples, Italy.
University of Campania "Luigi Vanvitelli" · ITTecnologie Avanzate (Italy) · IT

Funding

Università degli Studi della Campania Luigi Vanvitelli DRn15 04\01\2018
6 · The paper itself

Abstract

The lung cancer is the principle cause of the worldwide deaths and its prognosis is poor with a 5-year overall survival rate. Computed tomography (CT) gives many information about the prognosis, but the problem is the subject interpretation of the findings. Thanks to the computer-aided diagnosis/detection (CAD), it is possible to reduce the second opinion. "Radiomics" is an extension of CAD and overlaps the quantitative imaging data of the CT texture analysis (CTTA) with the clinical information, increasing the power and precision of the decision going through the personalized medicine. The aim of this study is to describe the role of the radiomics in the characterization of the pulmonary nodule. For this study, we retrospectively analyzed the images of the 87 NSCLC patients with a waiver of informed consent from the Institutional Review Board (IRB) at the Campania University "Luigi Vanvitelli" of Naples. All tumors were semiautomatically segmented by a radiologist with 10 years of experience using three diameters (AW Server 3.2). The examinations were acquired using 128 MDCT (GSI CT, GE) with a peak tube voltage of 120 kVp, tube current of 100 or 200 mA, and rotation times of 0.5 or 0.8 s. To confirm the imaging results, the FNAC was performed and for every nodule the following parameters were extracted: the presence of the solid component (named = 1), papillary component (named = 2), and mixed component (named = 3). Feature calculation was performed using the HealthMyne software and Integrated Platform That Enables Better Patient Management Decisions For Oncology. The radiologist uses the Rapid Precise Metrics (RPM)™ functionality to identify a lesion with the algorithm and these methods are put to work. The correlation between each feature and the tumor volume was calculated using a two-step cluster statistical analysis. In this retrospective study, in one year from 2018 to 2019 20 patients with lung adenocarcinoma confirmed with FNAC were enrolled. The pathologic results were subdivided into three categories: the solid architecture (group 1), papillary architecture (group 2), and mixed architecture (group 3). Nine lesions resulted with component 1, seven patients with component 2, and 3 patients with component 3. Eight females and 12 males with a median age 61 and 15 years (mean ± SD = 67.4 ± 9.7 years, range 39-73 years) were enrolled. The two results suggest, with p < 0.05, that the GGO variable is a good discriminating estimator of the kurtosis variable: GGO = "no" implies a high kurtosis value, while GGO = "yes" implies a low value. The numerous data obtained from the automatic analysis allow to have a fertile ground on which to develop a new concept of medicine which is precision medicine. The limit of this study is the poor sample. In the future, in order to have a more mature and consolidated discipline, it is necessary to increase the large scale of observations with further studies to establish the rigorous evaluation criteria. In order for radiomics to mature as a discipline in the future, it will be necessary to develop studies that consolidate its role to standardize the collected data.

Indexed as

Adenocarcinoma of LungAdultAgedAlgorithmsBiopsy, Fine-NeedleCytodiagnosisFemaleFollow-Up StudiesHumansLung NeoplasmsMaleMiddle AgedPrognosisRetrospective StudiesTomography, X-Ray ComputedTumor BurdenAdenocarcinomaFeature extractionLung cancerRadiomics

Identifiers

PMID32424733
OpenAlexW3027977292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.